drugset / Trial / NCT05859984
To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children
Phase 2
Unknown
345 enrolled
Seventh Medical Center of PLA General Hospital
The General Hospital of Central Theater Command · collabThe General Hospital of Northern Theater Command · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the clinical efficacy and safety of recombinant human interferon ω spray in treatment of viral upper respiratory tract infection in children aged by 3-12 years, and to explore the appropriate usage and dosage of the drug in treatment of upper respiratory tract infection caused by viruses.
Timeline
- Start
- 2023-05
- Primary completion
- 2024-05
- Completion
- 2024-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human interferon ω | Unknown | 2e+06 iu | Other |
| Subject | recombinant human interferon ω | Unknown | 4e+06 iu | Other |